Free Communications - Anal neoplasia

1:30 PM • FC 09-01 • HPV prevalence of rectal and scrotal squamous cell cancers in the United States > J. Jacqueline Mix 1:40 PM • FC 09-03 • Long-term performance of HPV genotyping, HPV E6/E7 mRNA expression, and P16/KI-67 cytology for detection of anal precancer in HIV+ MSM > M. Megan Clarke 1:50 PM • FC 09-04 • Anal and oral human papillomavirus infections in the new era of HIV-PrEP’S users > A. Aude Jary 2:00 PM • FC 09-05 • Anal liquid-based cytology and high risk human papilloma testing as composite endpoint in HIV-infected men who have sex with men to optimize screening for anal neoplasia > K. Karin Neukam 2:10 PM • FC 09-06 • Assessment of the learning curve of high-resolution anoscopy in HIV-infected men who have sex with men: how to improve the performance? > Y. Yusnelkis Milanés Guisado 2:20 PM • FC 09-07 • Topical ABI-1968, an acyclic nucleoside phosphonate prodrug for treatment of HPV-associated anal and cervical HSIL > O. Oranee Daniels 2:30 PM • FC 09-08 • Analysis of the prevalence of human papilloma virus and anomalous anal cytology in high-risk women > B. Belén López-Cavanillas 2:40 PM • FC 09-09 • Systematic review and meta-analysis on the prognostic significance of p16INK4A and high-risk-HPV DNA in anal squamous cell carcinoma > T. Theresa Obermueller 2:50 PM • FC 09-10 • Host cell DNA methylation markers for the detection of high-grade anal neoplasia and anal cancer in HIV+ men who have sex with men > R. Renske STEENBERGEN